Group 1: Neuralink and Brain-Computer Interface Stocks - Neuralink, founded by Elon Musk, plans to start large-scale production of brain-computer interface devices in 2026, leading to a significant surge in related stocks [1] - Nanjing Panda Electronics (00553) saw a rise of over 44%, while other companies like Xinwei Medical-B (06609), Micron Brain Science (02172), and Brainhole Laser-B (06681) increased by 11.90%, 17%, and 19.8% respectively [1] Group 2: Pharmaceutical Sector Performance - The pharmaceutical sector showed strong performance, with China's innovative drug licensing exceeding $100 billion last year [1] - Companies such as Gilead Sciences-B (01672), Cloudtop New Medicine (01952), and Innovent Biologics (01801) experienced stock increases of 8.85%, 5.65%, and 6.28% respectively [1] Group 3: Robotics and Technology Stocks - Woan Robotics (06600) saw its stock rise by over 27%, with a midday increase of 19.57% as it prepares to launch its first humanoid household robot [1] - The company reported a compound annual growth rate of 49% in revenue over the past three years [1] Group 4: Other Notable Stock Movements - Kuaishou-W (01024) increased by over 9%, with foreign investors optimistic about its revenue outlook for next year [1] - Fuhong Hanlin (02696) rose by 7% after three of its innovative cancer drugs received IND acceptance [1] - Kelun-Biotech (06990) gained over 7% following the approval of its clinical trial application for the new drug ITGB6 ADC SKB105 [2] - The Golden Group (03939) increased by 3.94% due to the successful implementation of key projects at the Solomon Gold Mine [3]

①马斯克称，其脑机接口公司将于2026年启动大规模脑机输出，行业正从早期向初步商业化阶段过渡，这 两家企业已提前实现千万元左右脑机接口业务营收；②行业有望进入高速发展期，这家国内企业可为脑机 接口客户提供植入体等关键部件制造，拥有医疗行业精密制造优势；③马斯克旗下Neuralink在侵入式脑 机领域探索迅速，国内少有企业完成相关突破，这家企业参股的国内脑机龙头企业是该领域技术代表之 一。 《金牌纪要库》是财联社VIP倾力打造的一款高端会议纪要类产品，结合财联社的媒体资源和行业圈层 优势，为投资者提供全面、深入的市场及行业洞察，以及专业分析和解读。 栏目专注于捕捉投资市场 的最新题材机会，通过一线记者的即时报道、资深编辑的专业整理，以及行业资深专家的深度访谈，为 投资者提供前瞻性、独家性、热门性及专业性的市场分析。 前言 ...

Market Performance - On January 5, 2026, the A-share market opened strongly, with the Shanghai Composite Index returning to 4000 points after 34 trading days, closing at 4011 points with an increase of over 1% [1] - The Shenzhen Component Index and the ChiNext Index rose by 1.87% and 2.15% respectively, with over 4000 stocks in the market experiencing gains [1] Brain-Computer Interface Sector - The brain-computer interface sector showed significant activity, rising over 13% by midday, with key stocks such as Beikang reaching a 30% limit up, and others like Sanbo Brain Science, Aipeng Medical, and Dineke hitting 20% limit up [1] - Elon Musk announced that his brain-computer interface company, Neuralink, plans to begin large-scale production of brain-computer interface devices in 2026, transitioning to a more streamlined and nearly fully automated surgical process [1] Aerospace and Precious Metals - In the commercial aerospace sector, stocks like Huazhu Gaoke and Feiwo Technology saw increases of 13.87% and 12.95% respectively, while Aerospace Hanyu rose over 10% [1] - In the precious metals sector, Hunan Silver and Hunan Gold increased by 9.68% and 2.7% respectively [1] - In the smart medical field, stocks such as Kefu Medical, Guhan Medicine, and Dahu Co. rose over 6% [1]

都回来了！ 1月5日早盘，沪指涨幅扩大至1%，沪指再度突破4000点。截至午间收盘，深证成指涨近2%，创业板指涨超 2%，脑机接口、存储芯片等方向领涨，沪深京三市上涨个股超4000只。其中，涨停及涨幅超过10%的股票一 度超过130只，强势霸屏！ 那么，究竟有何利好？分析人士认为，一是全球流动性宽松格局再度显现，这一点可以从最近虚拟货币的行情 得出一些结论；二是行业板块亦有显著利好，比如涨停板最多的脑机接口利好频频发酵。 流动性似乎回来了 1月份，资金又开始干活了。过去几天时间，比特币从8.7万美元涨至今天的9.3万美元，以太坊亦接近3200美 元，虚拟货币市场全线上涨。这便是全球流动性好转的显著特征。 国内方面，1月5日，Shibor短端品种多数下行。隔夜品种上行0.6BP报1.264%；7天期下行0.5BP报1.423%；14 天期下行6.1BP报1.457%；1个月期下行0.5BP报1.574%。与此同时，国债市场欲振乏力，流动性走强的同时， 风险偏好也回来了。 所以，有了股市集体走强的一幕。早盘，亚太市场全线发力，MSCI新兴市场指数涨1.1%，超过此前的历史收 盘纪录。日本和韩国的股市集体大涨。A股 ...

2026年A股开市了！首个交易日，三大指数早盘集体上涨，上证指数盘中重回4000点。盘面热点快速轮 动，脑机接口板块掀起涨停潮，倍益康"30cm"涨停，三博脑科等超20只个股涨停。保险板块表现活 跃，中国太保、新华保险盘中双双创历史新高。商业航天板块延续强势，金风科技等近20只个股封板。 此外，创新药、有色金属、游戏等板块盘中均表现积极。 您觉得哪个板块能成为2026年首周A股最热赛道？ 人脑工程板块掀涨停潮 创新药概念飙升 截至今日午间休市，沪指涨1.07%，深证成指涨1.87%，创业板指涨2.15%，沪深北三市半日成交16489 亿元，较上个交易日同期放量3240亿元。全市场超4000只个股上涨。人脑工程板块掀涨停潮，博拓生 物、熵基科技、三博脑科等10余只个股"20cm"涨停。 消息面上，埃隆·马斯克2025年12月31日在社交媒体上表示，其脑机接口公司"神经连接"（Neuralink） 将于2026年开始对脑机接口设备进行"大规模生产"，并转向"更加精简和几乎完全自动化的外科手术流 程"。（详见马斯克发声！301293，开盘"20cm"涨停） 开源证券最新研报表示，上述行业事件印证了脑机接口技术预计将 ...

Market Overview - On January 5, 2026, A-shares saw a collective rise, with the Shanghai Composite Index surpassing 4000 points, closing at 4011.45, up 1.07% [1][2] - The trading volume reached 3.82 billion shares, with a total market capitalization of 65.50 trillion [2] Sector Performance - The semiconductor, insurance, and medical device sectors experienced significant gains, while the oil and gas, and tourism sectors faced declines [3] - Brain-computer interface (BCI) concept stocks surged, leading to a "limit-up" phenomenon in several stocks [5] Key Stocks in BCI Sector - Notable BCI stocks included Xiangyu Medical, Guanhao Biological, Meihao Medical, Aipeng Medical, and Lepu Medical, all achieving a 20% limit-up [5][7] - Other stocks like Sanqi Interactive Entertainment and Innovation Medical recorded a 10% limit-up [5] Semiconductor Sector Highlights - The semiconductor sector also showed strength, with stocks like Dongwei Semiconductor and *ST Tianlong hitting the 20% limit-up [11][12] - TSMC announced it received U.S. government approval to import chip manufacturing equipment to its Nanjing facility, which is expected to boost the sector [15] Insurance Sector Insights - The insurance sector saw a rise, with Xinhua Insurance up 7.53%, China Pacific Insurance up 6.16%, and China Life Insurance up over 5% [17] - The insurance industry reported a total premium income of 57,629 billion for the first 11 months of 2025, a year-on-year increase of 7.6% [17]

今日，是2026年第一个交易日，A股开门红，上证指数高开高走突破4000点大关，科创50大涨逾4%， 盘中也一度站上1400点，深证成指、创业板指、北证50等均高开高走。超4100只个股上涨，成交呈快速 放大趋势。 盘面上，人脑工程、医药生物、芯片、航天装备等板块涨幅居前，油气开采、海南自贸、酒店餐饮、航 空机场等板块跌幅居前。 人脑工程概念飙升 人脑工程概念股早间大幅高开高走，板块指数放量飙升逾11%，创历史新高，开盘不到1小时成交就超 过前一交易日全天成交。板块内个股掀涨停潮，倍益康开盘秒速30%涨停，博拓生物、三博脑科、翔宇 医疗批量20%涨停，创新医疗、国际医学等近40股涨停或涨超10%。 | ▼指 | 名称 代码 | | 涨幅%, | 现价 | 涨跌 | 洪价 | 河价 | | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 920199 倍益康 | R | 29.98 | 44.96 | 10.37 | 44.96 | | | 2 | 688767 博拓生物 | K | 20.01 | 45.34 | 7.56 | 45.34 | | | ...

一、【早盘盘面回顾】 智通财经1月5日讯，市场早盘高开高走。时隔34个交易日，上证指数重回4000点，创业板指涨超2%。 沪深两市半日成交额1.64万亿，较上个交易日放量3238亿。盘面上热点快速轮动，全市场超4000只个股 上涨，其中98只个股涨停。从板块来看，脑机接口概念爆发，二十余只成分股涨停，三博脑科、美好医 疗、创新医疗、倍益康、塞力医疗涨停。商业航天概念反复活跃，中国卫通5天3板。保险板块走强，新 华保险、中国太保双双续创历史新高。半导体产业链表现活跃，亚翔集成、圣晖集成涨停。下跌方面， 海南自贸概念集体大跌，海南发展跌停。截至收盘，沪指涨1.07%，深成指涨1.87%，创业板指涨 2.15%。 个股来看，今日早盘涨停数量为79家（不包括ST及未开板新股），封板率为77%，连板股数量为14家， 锋龙股份7连板，雷科防务4连板，南兴股份3连板，农心科技、利欧股份、北斗星通、友邦吊顶、王子 新材、索菱股份、中天火箭、顺控发展、城建发展、烽火通信、中国卫通2连板。 板块上，脑机接口全线爆发，博拓生物、航天长峰、倍益康、三博脑科、翔宇医疗、伟思医疗、诚益 通、爱朋医疗、创新医疗等20余股涨停。 | | | ...

1月5日，时隔34个交易日，上证指数盘中重回4000点。 商业航天概念大面积高开 1月5日早盘商业航天概念大面积高开，金风科技、雷科防务、联创光电等多股涨停，久之洋、北斗星通、中国卫星、顺灏股份等高开超5%。 板块题材上，脑机接口、保险、半导体、商业航天、创新药、游戏、有色金属板块涨幅居前；海南自贸区、旅游及酒店、银行、跨境支付、猪肉板块跌幅 居前。 脑机接口板块掀涨停潮 脑机接口板块早盘掀起涨停潮，倍益康30cm涨停，三博脑科（301293）、美好医疗（301363）、翔宇医疗等超20股涨停。 消息面上，马斯克近日在社交媒体上表示，其脑机接口公司Neuralink将于2026年开始对脑机接口设备进行"大规模生产"，并同步推进一种流程高度精简、 几乎完全自动化的手术方案。 马斯克表示，接下来设备中的电极丝将直接穿过硬脑膜，而无需将其切除——这是一项非常重大的突破。 | 大盘 | 板块 | 个股 | 看盘广场 | | --- | --- | --- | --- | | 图午间休盘 | | | -21.47亿 大盘资金净流入 | | 13:00 继续开盘 | | | | | 上证指数 | 深证成指 | | 创业板 ...

Core Viewpoint - The A-share market experienced a significant surge on January 5, 2026, driven by the brain-computer interface (BCI) sector, with the index rising over 12% and multiple stocks hitting their daily limit up [1] Group 1: Market Performance - On the opening day of the A-share market, stocks related to brain-computer interfaces saw a collective rally, with stocks like BeiYikang (920199.BJ) hitting a 30% limit up and others such as Botao Bio (688767.SH) and Sanbo Neuroscience (301293.SZ) reaching 20% limit up [1] - A total of 11 stocks in the BCI sector experienced a 20% limit up, indicating strong investor interest and market momentum [1] Group 2: Technological Developments - The surge in the BCI sector was catalyzed by news of mass production of BCI devices by Elon Musk's company, Neuralink, expected to begin in 2026, which includes advancements in surgical procedures [1] - Neuralink's device will feature electrodes that can penetrate the dura mater without removal, marking a significant technological breakthrough [1] Group 3: Domestic Developments - In China, several companies are emerging that parallel Neuralink's technological approach, with Guotai Junan Securities declaring 2025 as the year for clinical trials of invasive and semi-invasive BCIs [2] - Companies like Borui Kang have completed clinical trials, with expectations for regulatory approval in 2026, while other firms are also making progress in BCI technology [2] Group 4: Market Projections - Open Source Securities predicts that BCI technology will redefine human-robot interaction and is expected to commercialize by 2026, expanding from medical applications to AI and robotics [3] - The global BCI market is projected to grow to approximately $12.4 billion by 2034, with a CAGR of 17% from 2025 to 2034, indicating strong future growth potential [3]